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Introduction
Acute myocardial infarction (AMI) is a global health problem. In China, the number of patients with MI was 2.5 million in 2012, and this number is expected to increase over the next ten years [1] . For patients with AMI, early and successful myocardial reperfusion, such as thrombolytic therapy or primary percutaneous coronary intervention, is the most effective strategy for reducing infarct size and improving clinical outcome. However, the resulting in irreversible myocardial cell damage and increased infarct size. This phenomenon is termed myocardial ischemia/reperfusion (I/R) injury [2] . Although patients with AMI may receive optimal reperfusion therapy, the mortality is still 10% because of myocardial I/R injury [3] . Therefore, the prevention and treatment of myocardial I/R injury has become one of the most important issues in AMI research.
[6] and anticancer effects [7] . Recently, Gandhi et al. [8] showed that a continuous 15-day hesperidin pretreatment could protect against myocardial I/R injury in rats by suppressing hesperidin pretreatment attenuated hypoxic-ischemic brain injury in neonatal rats. Hence, we speculated that a 3-day hesperidin pretreatment may also protect against myocardial I/R injury. However, the mechanism underlying hesperidin protection against I/R injury remains elusive.
High mobility group box 1 protein (HMGB1) is a ubiquitous, non-chromosomal cardiovascular diseases, including myocardial I/R injury [10] [11] [12] [13] . Previous studies have demonstrated that HMGB1 may contribute to the pathophysiological process of myocardial HMGB1 by several drugs, such as minocycline and ethyl pyruvate, can reduce myocardial I/R injury in rats [15, 16] . In addition, Kawaguchi et al. [17] demonstrated that hesperidin suppressed HMGB1 expression in an endotoxin shock model. Thus, we speculate that the cardioprotective effects of hesperidin may be related to its inhibitory effects on HMGB1 expression. Phosphoinositide 3-kinase (PI3K) plays an important role in the control of cell growth, proliferation, survival and migration [18] . Activation of Akt, which is downstream of PI3K, of the protective mechanism of ischemic preconditioning that inhibits myocardial I/R injury abolish the cardioprotective effects of simvastatin on I/R injury. Wang et al. [23] reported that the PI3K pathway may be associated with the inhibition of HMGB1 expression in a rat pathway may mediate the protective effects of hesperidin in neural crest cell survival. Hence, we hypothesize that hesperidin-induced HMGB1 expression inhibition depends on the PI3K/Akt pathway.
In this study, we investigated whether a short-term hesperidin pretreatment could alleviate myocardial I/R injury and whether the cardioprotective effects of hesperidin involve HMGB1 inhibition and the PI3K/Akt pathway. 
Materials and Methods

Animals
Eighty male Sprague-Dawley rats (200-250g) were obtained from the animal experiment center of Wuhan University, China. All experimental protocols conformed to the Guideline for the Care and Use of and were approved by the Institutional Animal Care and Use Committee of Wuhan University (Approval Number: 2015-0536).
Myocardial I/R model and experimental design
and monitored with an electrocardiogram using a computer-based EP system (LEAD2000B, Jinjiang Ltd., Chengdu, China). Then, the myocardial I/R rat model was established with a 30-min left anterior descending -h reperfusion, as previously described [23] . At the end of the reperfusion period, the animals were euthanized, and their blood and hearts were collected for various biochemical analyses.
operated (SO): 0.5% CMC-Na; (ii) I/R: 0.5% CMC-Na; (iii) Hesperidin (100 mg/kg) + I/R (Hesp100-I/R); (iv) days, rats in the SO group were subjected to surgical manipulation without ligature of the LAD, but rats in To further clarify the protective effects of hesperidin on myocardial I/R injury, we conducted another Sigma-Aldrich, St. Louis, USA) [23] via the caudal vein 30 min before LAD occlusion, and other three groups
Histopathological examination
were stained with hematoxylin and eosin (H&E) to observe myocardial damage. To quantify the histological scored in a blinded manner by two individuals, as previously described [25] . The scores were as follows: 0, no damage; 1 (mild), interstitial edema and focal necrosis; 2 (moderate), diffuse myocardial cell swelling
Assessment of myocardial injury
To assess creatine kinase (CK) and lactate dehydrogenase (LDH) levels, blood samples were collected and centrifuged at 3000 rpm for 15 min. Supernatants were stored at -20°C for later analyses. Standard techniques were performed using commercial kits (Nanjing Jiancheng Bioengineering Institute, Nanjing, China) according to the manufacturer's instructions. LDH and CK were used as indices of myocardial injury.
Assessment of infarct size
Infarct size was determined using 2,3,5-triphenyltetrazolium chloride (TTC, Sigma-Aldrich, St. Louis, USA) staining as previously described [8, 26] . In brief, after reperfusion, the LAD was occluded again and 2 ml of 1% Evans blue dye (Sigma-Aldrich, St. Louis, USA) was injected via the femoral vein. Each frozen heart (-80°C, 15 min) was then cut (approximately 2 mm) from the apex to the base. The slices were incubated linked immunosorbent assays (Nanjing Jiancheng Bioengineering Institute, Nanjing, China) were used .
Myocardial SOD activity and MDA content were measured using commercial kits (Nanjing Jiancheng Bioengineering Institute, Nanjing, China) according to the manufacturer's instructions. These markers were used as indices of oxygen free radical and lipid superoxide levels in the myocardium, respectively.
Pulverized, frozen ischemic areas of the left ventricle samples were analyzed by western blot analysis, as previously described [27] . In brief, equal amounts of protein were electrophoresed in a 10% SDSpolyacrylamide gel and transferred to a nitrocellulose membrane. After blocking with 5% non-fat dry milk membrane was washed and incubated with secondary antibodies (Boster, Wuhan, China) at 37°C for 2 h. The protein bands were visualized using an enhanced chemiluminescence system, and glyceraldehyde-3-phosphate dehydrogenase (GAPDH, Boster, Wuhan, China) was used as an internal control. The following primary antibodies were used for western blot analysis: anti-Bax (1:1000), anti-Bcl-2 (1:1000), anti-t-Akt Boster, Wuhan, China). Five hearts in each group were used for the western blot analysis.
Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assays were performed to determine the extent of apoptosis in the myocardium using a commercial kit (Roche Applied Science, Indianapolis, USA) according to the manufacturer's instructions. Only the nuclei of the apoptotic cells were stained brown.
, and the AI was calculated cells / total number of cells counted.
three times with TBS-T. Then, the sections were incubated with a biotinWuhan Jiayuan Quantum Dots Co. Ltd., Wuhan, China) at 37°C for 30 min. After being washed three times in TBS-T and incubated with quantum dot-conjugated streptavidin (1:150, Wuhan Jiayuan Quantum Dots Co.
SPSS 17.0 was used for data analysis. All data are expressed as the mean ± SD. A one-way analysis of variance or a Welch test was used for comparisons among groups and the Student-Newman-Keuls or Dunnett's T3 test was used for post hoc multiple comparisons. P values < 0.05 were considered statistically 
Results
Pretreatment with hesperidin promoted histopathological changes and reduced
To determine the optimal dose of the 3-day hesperidin pretreatment, we evaluated histopathological changes using H&E staining and detected biomarkers of myocardial damage (CK and LDH) in serum following treatment with different doses of hesperidin. As shown in Fig. 1A , the myocardial structure in the SO group exhibited a regular arrangement, edema and hemorrhage. The myocardial damage in the hesperidin groups was less than that CK and LDH levels to assess myocardial injury (Fig. 1B, 1C and 1D) . Compared with the SO group, the I/R group exhibited a markedly increased damage score as well as serum CK and LDH levels (p lower damage scores as well as decreased serum CK and LDH levels, suggesting that a shortterm hesperidin pretreatment could attenuate myocardial I/R injury. However, only groups
Hesperidin pretreatment reduced myocardial injury after I/R
the myocardial infarction size and the serum levels of CK and LDH were measured using TTC staining and an automatic biochemistry analyzer. Compared with the I/R group, the p < 0.05, Fig. 2A and in the SO group (p lowered the serum levels of CK and LDH, which were increased in the I/R group. These results suggested that hesperidin could attenuate myocardial I/R injury. However, administration of p < 0.05).
Hesperidin pretreatment suppressed myocardial apoptosis
To investigate the effects of hesperidin on myocardial apoptosis in I/R injury, the AI and the expression of apoptosis-related proteins (the Bcl-2/Bax ratio, Bcl-2 and Bax) in the myocardium were measured using TUNEL assays and western blot analysis, respectively. As shown in Fig. 3 , compared with the SO group, the AI and the level of Bax expression were markedly increased in the I/R group; in addition, both Bcl-2 expression and the Bcl-2/Bax p < 0.05). The hesperidin pretreatment group exhibited striking decreases in the AI and Bax expression and increases in the Bcl-2/Bax ratio and Bcl-2 expression compared with those of the I/R group (p < 0.05), indicating that hesperidin could reduce myocardial apoptosis. Conversely, administration of p < 0.05).
I/R group (p p expression To investigate the possible mechanism underlying the effects of hesperidin during myocardial I/R injury, the levels of HMGB1, p-Akt and t-Akt expression in the myocardium analysis. As shown in Fig. 6A , the HMGB1 (red) signals detected in the I/R group were much higher than those in the SO group. Hesperidin substantially reduced the I/R-induced HMGB1 increased and p-Akt expression was markedly decreased in the I/R group (p < 0.05). Hesperidin markedly suppressed the increased mean densitometry values and HMGB1 expression as well as the decreased p-Akt expression induced by I/R (p < 0.05, Fig. 6B, 6C and 6D), indicating that hesperidin could activate the PI3K/Akt pathway and inhibit HMGB1 p < groups (p > 0.05, Fig. 6E ).
Discussion
A growing number of epidemiological studies have consistently shown that diets rich in the cardiovascular protective effects of orange juice in healthy, middle-aged, moderately overweight men by decreasing diastolic blood pressure and increasing endotheliumdependent microvascular reactivity. Using the dose conversion between humans and rats (human:rat, 1:6.17, by body surface area comparisons) [31] , hesperidin dose of 200 mg/ -fold greater than a nutritional dose. Gandhi et al. [8] reported that a 15-day hesperidin pretreatment at 100 mg/kg/ day could protect against myocardial I/R injury and limit infarct size. Agrawal et al. [32] demonstrated that a 2-week hesperidin pretreatment at 100 mg/kg/day attenuated myocardial I/R injury and reduced infarct size in diabetic rats. These studies suggested that relatively long-term hesperidin administrations could attenuate myocardial I/R injury. Rong injury in neonatal rats. Selvaraj et al. [5] showed that a 7-day hesperidin pretreatment could isoproterenol-induced model of myocardial infarction. Consistent with previous studies, we histopathological changes and decreased both myocardial damage as well as infarct size caused by I/R injury. These results suggest that short-term hesperidin conditioning could protect against myocardial I/R injury.
Hesperidin reduced myocardial I/R injury by inhibiting myocardial apoptosis, the
Myocardial I/R injury is a complex pathophysiological process in which myocardial cell death in myocardial I/R injury, which leads to the loss of myocardium and functional , including those of the antiand pro-apoptosis proteins of the Bcl-2 family. Bcl-2 (an anti-apoptosis protein) and Bax (a pro-apoptosis protein) both belong to the Bcl-2 family. The ratio of Bcl-2/Bax plays crucial roles in determining the extent of apoptosis in I/R heart [35] . Agrawal et al. [36] reported that hesperidin inhibited myocardial apoptosis by upregulating the ratio of Bcl-2/Bax in an isoproterenol-induced model of myocardial infarction in diabetic rats. Consistent with these damage during myocardial I/R injury, suggesting that hesperidin could inhibit myocardial apoptosis and further attenuate myocardial I/R injury.
, including , contributes to I/R injury [37] . Free radicals, the main products of oxidative stress, are actively involved in myocardial I/R injury and can be assessed by MDA, a marker of oxidative stress, and SOD, antioxidant and anti-lipid peroxidative properties of hesperidin on isoproterenol-induced oxidative stress in myocardial infarction. Similarly, our data showed that hesperidin inhibited myocardial infarct size. These results suggest that the cardioprotective effects of hesperidin Hesperidin protected against myocardial I/R injury by inhibiting HMGB1 expression et al. [15] reported that HMGB1 can promote the apoptosis of myocytes in a dose-dependent manner. Additionally, Zhang damage in severe acute pancreatitis. In the present study, increased HMGB1 expression was in the I/R group, thus suggesting that high levels of HMGB1 may contribute to cardiomyocyte alleviated I/R injury. Kawaguchi et al. [17] reported that hesperidin can suppress the may attenuate I/R injury by inhibiting HMGB1 expression.
The PI3K/Akt pathway, a major regulator of cell growth and survival, is activated in 2 preconditioning protected against myocardial I/R injury through PI3K/Akt pathway activation. These studies demonstrated that PI3K/Akt pathway activation could ameliorate I/R injury in pathway to protect against neonatal hypoxic-ischemic brain injury. Furthermore, Wang et al. [23] reported that PI3K pathway activation inhibited HMGB1 expression and attenuated myocardial I/R injury. In the present study, we found that hesperidin activated the PI3K/Akt , results indicate that hesperidin can protect against myocardial I/R injury by inhibiting HMGB1 via PI3K/Akt pathway activation.
Conclusions
In the present study, we demonstrated that a short-term pretreatment with hesperidin -sponse and oxidative stress. We also showed that these protective effects of hesperidin were predominantly due to HMGB1 expression inhibition via PI3K/Akt pathway activation.
Study limitations
ischemia. In the present study, we only detected the levels of p-Akt, SOD and MDA in the kinetics of Akt phosphorylation or oxidative stress during reperfusion.
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